Last reviewed · How we verify

NCT04323683

The Effect of Progesterone on Human Endometrium

Completed Last updated 26 March 2020
What this trial tests

trial testing Microarray in Fertility in 12 participants. Completed in 31 July 2019.

Timeline
1 February 2019
Primary endpoint
31 July 2019
31 July 2019

Quick facts

Lead sponsorUniversity of Nottingham
StatusCompleted
Study typeOBSERVATIONAL
Enrollment12
Start date1 February 2019
Primary completion31 July 2019
Estimated completion31 July 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Nottingham

Who can join

Adults 18 to 35, female only, with Fertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the relationship between progesterone levels and endometrial gene expression

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fertility

Currently open trials in the same condition.

Other University of Nottingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04323683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing